This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/mesh/concept/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01442/identifier/wikipedia/
n15http://linked.opendata.cz/resource/drugbank/drug/DB01442/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB01442/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB01442/identifier/drugbank/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB01442/identifier/chemspider/

Statements

Subject Item
n2:DB01442
rdf:type
n3:Drug
n3:description
MMDA, or 3-methoxy-4,5-methylenedioxyamphetamine, is a stimulant and psychedelic drug of the amphetamine class. It also acts as an entheogen and an entactogen. MMDA bears resemblance to the psychopharmacologically active essential oils elemicin and myristicin found in nutmeg. The effects of MMDA includes feelings of euphoria and warmth, as well as realistic closed-eye visuals.
n3:group
experimental illicit
n3:indication
MMDA is a recreational drug. It has no current medical uses and is a Schedule I controlled substance in the USA at present.
owl:sameAs
n11:DB01442 n16:DB01442
dcterms:title
MMDA
adms:identifier
n8:MMDA_%2528psychedelic%2529 n12:24386 n13:46506802 n14:DB01442 n15:26175
n3:mechanismOfAction
The mechanism that produces the psychedelic activity of MMDA has not been definitively established. There are, as of the present time, no reported studies on the human pharmacokinetics or metabolism of MMDA. Based on its structural relationship with other similar drugs for which the pharmacology is known, it is likely that MMDA has multiple mechanisms of action, and probably acts both as a 5HT2A agonist in a similar manner to hallucinogenic amphetamines such as DOM, and also as a serotonin releaser by reversing the direction of the serotonin reuptake transporter in a similar manner to MDMA.
n3:synonym
5-Methoxy-3,4-methylenedioxyamphetamine 3-Methoxy-4,5-methylenedioxyphenylisopropylamine 3-Methoxy-alpha-methyl-4,5-methylenedioxyphenethylamine 3-METHOXY-METHYLENEDIOXYAMPHETAMINE Amphetamine, 3,4-methylenedioxy-5-methoxy (+-)-mmda
n5:hasConcept
n6:M0052469
n3:IUPAC-Name
n4:271B4BA7-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4BAD-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4BAC-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4BA9-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4BAA-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4BAB-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4BA5-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4BA6-363D-11E5-9242-09173F13E4C5 n4:271B4BA3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4BA4-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4BB3-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4BB4-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4BAE-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4BAF-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4BB1-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4BB0-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4BB2-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
13674-05-0
n3:Bioavailability
n4:271B4BB8-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4BBA-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4BBB-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4BB7-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4BB6-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4BB9-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4BA8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4BB5-363D-11E5-9242-09173F13E4C5